HLA antigens in Omanis with blinding trachoma: Markers for disease susceptibility and resistance

British Journal of Ophthalmology

Volumn 81, Issue 6, 1997, Pages 431-434

  White, Arthur G ^a   Bogh, Jorn ^b,c   Leheny, William ^a   Kuchipudi, Padmavathi ^a   Varghese, Mathew ^a   Al Riyami, Hamad ^a   Al Hashmi, Sulieman ^a   Daar, Abdallah S ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^c Eyeclinic   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; HLA DR7 ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE RESISTANCE; HLA SYSTEM; HUMAN; OMAN; PRIORITY JOURNAL; TRACHOMA;

EID: 0030742867     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.81.6.431     Document Type: Article

References (21)

1. Sanford-Smith J. In: Eye diseases in hot climates. Bristol: Wright, 1986;7:80-92.
2. Mabey D, Mabey D. New hope for trachoma control. Community Eye Health 1994;7:17-8.
3. Dawson CR, Jones BR, Tarizzo ML. Guide to trachoma control. Geneva: WHO, 1981;3:22.
4. Bobo L, Munoz B, Viscidi R, Quinn T, Mkocha H, West S. Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay. Lancet 1991;338:847-50.
5. Taylor HR, Rapoza PA, West S, Johnson S, Munoz B, Katala S, et al. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci 1989;30:1823-33.
6. Mabey DCW, Bailey RL, Dunn D, D Jones, Williams JHD, Whittle HC, et al. Expression of MHC Class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease. J Clin Pathol 1991;44:285-9.
7. Courtright P, Lewallen S, Howe R. Cell-mediated immunity in trachomatous scarring. Evidence from a leprosy population. Ophthalmology 1993;100:98-104.
8. Conway DJ, Holland MJ, Campbell AE, Bailey RL, Krausa P, Peeling RW, et al. HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis-endemic population. J Infect Dis 1996;174:643-6.
9. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull WHO 1987;65:477-83.
10. Venkataram MN, White AG, Leheny WA, Suwaid AR, Daar AS. HLA antigens in Omanis with vitiligo. Clin Exp Derm 1995;20:35-7.
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215-8.
12. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43: 18-27.
13. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956;20:309-11.
14. Altman DG. Practical statistics for medical research. 1st ed. London: Chapman and Hall 1991;266-8.
15. Thorsby E. HLA-associated disease susceptibility - which genes are primarily involved? Immunologist 1995;3:51-8.
16. Hill AVS, Allsopp CEM, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Commom West African HLA antigens are associated with protection from severe malaria. Nature 1991;352:595-600.
17. Joko S, Numaga J, Fujino Y, Masuda K, Hirata R, Maeda H. HLA and uveitis in leprosy. Nippon Ganka Gakkai Zasshi 1995;99:1181-5.
18. Todd JR, West BC, McDonald JC. Human leucocyte antigen and leprosy: study in northern Louisiana and review. Rev Infect Dis 1990;12:63-74.
19. Mehra NK, Rajalingan R, Mitra DK, Taneja V, Giphart MJ. Variants of HLA-DR2/DR51 group haplotypes and susceptibility to tuberculoid leprosy and pulmonary tuberculosis in Asian Indians. Int J Leprosy Mycobact Disorders 1995;63:241-8.
20. Brahmajothi V, Pitchappan RM, Kakkanaiah VN, Sashidhar M, Rajaram K, Ramu S, et al. Association of pulmonary tuberculosis and HLA in south India. Tubercle 1991;72: 123-32.
21. El-Asrar AMA, Van Den Oord JJ, Geboes K, Missotten L, Emarah MH, Desmet V. Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol 1989;73:276-82.